Terms: = Liver cancer AND STIL, SIL, 6491, ENSG00000123473, Q15468 AND Treatment
28 results:
1. Effect of bevacizumab administered prior to transarterial chemoembolization on the therapeutic effects of lenvatinib given post-TACE in primary liver cancer patients.
Dang Z; Jiang L; Huang F
Int J Clin Pharmacol Ther; 2023 Oct; 61(10):423-429. PubMed ID: 37548453
[TBL] [Abstract] [Full Text] [Related]
2. "A new LC-MS/MS method for the simultaneous quantification of abemaciclib, its main active metabolites M2 and M20, and letrozole for therapeutic drug monitoring".
Soledad Poetto A; Posocco B; Zanchetta M; Gagno S; Orleni M; Canil G; Alberti M; Puglisi F; Toffoli G
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Sep; 1207():123403. PubMed ID: 35940043
[TBL] [Abstract] [Full Text] [Related]
3. Case Report: Baricitinib as an Alternative in the Maintenance Therapy for Macrophage Activation Syndrome Secondary to Nodular Panniculitis.
Yi G; Huang Z; Huang Z; Wang Y; Deng W; Zheng S; Li T
Front Immunol; 2022; 13():914265. PubMed ID: 35874753
[TBL] [Abstract] [Full Text] [Related]
4. sil-2R- an Immuno-biomarker for Prediction of Metastases in Uveal Melanoma.
Barak V; Kalickman I; Pe'er J
Anticancer Res; 2022 Mar; 42(3):1447-1453. PubMed ID: 35220238
[TBL] [Abstract] [Full Text] [Related]
5. Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma.
Makkouk A; Yang XC; Barca T; Lucas A; Turkoz M; Wong JTS; Nishimoto KP; Brodey MM; Tabrizizad M; Gundurao SRY; Bai L; Bhat A; An Z; Abbot S; Satpayev D; Aftab BT; Herrman M
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34916256
[TBL] [Abstract] [Full Text] [Related]
6. Elevated soluble programmed death-ligand 1 levels indicate immunosuppression and poor prognosis in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization.
Ma XL; Qu XD; Yang WJ; Wang BL; Shen MN; Zhou Y; Zhang CY; Sun YF; Chen JW; Hu B; Gong ZJ; Zhang X; Pan BS; Zhou J; Fan J; Yang XR; Guo W
Clin Chim Acta; 2020 Dec; 511():67-74. PubMed ID: 32979338
[TBL] [Abstract] [Full Text] [Related]
7. silibinin A decreases statin‑induced PCSK9 expression in human hepatoblastoma HepG2 cells.
Dong Z; Zhang W; Chen S; Liu C
Mol Med Rep; 2019 Aug; 20(2):1383-1392. PubMed ID: 31173243
[TBL] [Abstract] [Full Text] [Related]
8. Intratumoral infiltrating lymphocytes correlate with improved survival in colorectal cancer patients: Independent of oncogenetic features.
Nazemalhosseini-Mojarad E; Mohammadpour S; Torshizi Esafahani A; Gharib E; Larki P; Moradi A; Amin Porhoseingholi M; Asadzade Aghdaei H; Kuppen PJK; Zali MR
J Cell Physiol; 2019 Apr; 234(4):4768-4777. PubMed ID: 30370522
[TBL] [Abstract] [Full Text] [Related]
9. Combination of transcatheter arterial chemoembolization and interrupted dosing sorafenib improves patient survival in early-intermediate stage hepatocellular carcinoma: A post hoc analysis of the START trial.
Lee TY; Lin CC; Chen CY; Wang TE; Lo GH; Chang CS; Chao Y
Medicine (Baltimore); 2017 Sep; 96(37):e7655. PubMed ID: 28906355
[TBL] [Abstract] [Full Text] [Related]
10. Phase I study of low-dose metronomic temozolomide for recurrent malignant gliomas.
Wong ET; Timmons J; Callahan A; O'Loughlin L; Giarusso B; Alsop DC
BMC Cancer; 2016 Nov; 16(1):914. PubMed ID: 27876012
[TBL] [Abstract] [Full Text] [Related]
11. IL-15/sil-15Rα gene transfer suppresses Lewis lung cancer growth in the lungs, liver and kidneys.
Sun H; Liu D
Cancer Gene Ther; 2016; 23(2-3):54-60. PubMed ID: 26742578
[TBL] [Abstract] [Full Text] [Related]
12. Higher proliferation of peritumoral endothelial cells to IL-6/sil-6R than tumoral endothelial cells in hepatocellular carcinoma.
Zhuang PY; Wang JD; Tang ZH; Zhou XP; Quan ZW; Liu YB; Shen J
BMC Cancer; 2015 Nov; 15():830. PubMed ID: 26525581
[TBL] [Abstract] [Full Text] [Related]
13. Rescue therapy with intravenous silibinin in liver transplant recipients with recurrent HCV hepatitis - two case reports.
Socha Ł; Karpińska E; Jurczyk K; Laurans Ł; Bander D; Lachtara M; Wawrzynowicz-Syczewska M
Ann Transplant; 2014 Apr; 19():161-4. PubMed ID: 24714452
[TBL] [Abstract] [Full Text] [Related]
14. silybin-mediated inhibition of Notch signaling exerts antitumor activity in human hepatocellular carcinoma cells.
Zhang S; Yang Y; Liang Z; Duan W; Yang J; Yan J; Wang N; Feng W; Ding M; Nie Y; Jin Z
PLoS One; 2013; 8(12):e83699. PubMed ID: 24386256
[TBL] [Abstract] [Full Text] [Related]
15. Primary hepatic peripheral T-cell lymphoma treated with corticosteroid.
Miyashita K; Tomita N; Oshiro H; Matsumoto C; Nakajima Y; Ito S; Matsumoto K; Fujita H; Ishigatsubo Y
Intern Med; 2011; 50(6):617-20. PubMed ID: 21422689
[TBL] [Abstract] [Full Text] [Related]
16. Target ability and therapy efficacy of immunoliposomes using a humanized antihepatoma disulfide-stabilized Fv fragment on tumor cells.
Hu H; Chen D; Liu Y; Deng Y; Yang S; Qiao M; Zhao J; Zhao X
J Pharm Sci; 2006 Jan; 95(1):192-9. PubMed ID: 16315243
[TBL] [Abstract] [Full Text] [Related]
17. Twenty-year experience with liver transplantation for hepatocellular carcinoma.
Island ER; Pomposelli J; Pomfret EA; Gordon FD; Lewis WD; Jenkins RL
Arch Surg; 2005 Apr; 140(4):353-8. PubMed ID: 15837885
[TBL] [Abstract] [Full Text] [Related]
18. [Prognostic factors in patients with small cell lung cancer].
Song LH; Song XR; Zhang XQ; Qi JL; Li XJ; Tian H; Bu B
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):413-6. PubMed ID: 15355646
[TBL] [Abstract] [Full Text] [Related]
19. Patients with advanced primary hepatocellular carcinoma treated by melatonin and transcatheter arterial chemoembolization: a prospective study.
Yan JJ; Shen F; Wang K; Wu MC
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):183-6. PubMed ID: 14607735
[TBL] [Abstract] [Full Text] [Related]
20. The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases.
Kallen KJ
Biochim Biophys Acta; 2002 Nov; 1592(3):323-43. PubMed ID: 12421676
[TBL] [Abstract] [Full Text] [Related]
[Next]
